See clinical tips available (linked below) on individual LAIs for more detailed information about what clinicians should know.
LAI Drug Name | FDA Indications | Dosing Tips |
***First Generation Antipsychotics*** | ||
Schizophrenia | 2-6 weeks Overlap PO 4-8 weeks | |
Schizophrenia | 4 weeks | |
***Second Generation Antipsychotics*** | ||
Schizophrenia | 4 weeks | |
Schizophrenia | 4 or 6 or 8 weeks | |
Schizophrenia | Only for initiation of Aristada once | |
Schizophrenia | 4 weeks | |
Schizophrenia | 12 weeks | |
Schizophrenia *age 13+ | 2 weeks | |
Schizophrenia | 4 weeks | |
Schizophrenia | 2 or 4 weeks |